research Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial
Setipiprant did not significantly improve hair growth in men with hair loss.
Search
for
Sort by
Research
150-180 / 389 resultsresearch Treatment of Pediatric Alopecia Areata: A Systematic Review
Topical corticosteroids are the best initial treatment for children's alopecia areata.
research Prostaglandin Analogs for Hair Growth: Great Expectations
Prostaglandin analogs like Latanoprost might help grow hair on the scalp and body.
research A Systematic Review on Drug Re-Profiling/Re-Purposing
The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.
research Characterization of an In Vivo Model for the Study of Eyelash Biology and Trichomegaly: Mouse Eyelash Morphology, Development, Growth Cycle, and Anagen Prolongation by Bimatoprost
The study showed that mouse eyelashes can be used to study eyelash growth and that bimatoprost makes them longer and more numerous.
research Successful Use of Bimatoprost in the Treatment of Eyelash Alopecia
Bimatoprost helped a girl grow her eyelashes back quickly and without serious side effects.
research Laser-Assisted Drug Delivery for the Treatment of Androgenetic Alopecia: Ablative Laser Fractional Photothermolysis to Enhance Cutaneous Topical Delivery of Platelet-Rich Plasma — With or Without Concurrent Bimatoprost and/or Minoxidil
Laser-assisted delivery of PRP, with or without bimatoprost and minoxidil, can effectively stimulate hair growth.
research Preparation of Topical Bimatoprost with Enhanced Skin Infiltration and In Vivo Hair Regrowth Efficacy in Androgenic Alopecia
Bimatoprost cream can help regrow hair in baldness.
research Comparison of the Efficacy and Safety of Using 0.01% Versus 0.03% Bimatoprost for the Treatment of Eyebrow Hypotrichosis: A Randomized, Double-Blind, Split-Face, Comparative Study
Both 0.01% and 0.03% bimatoprost safely improve eyebrow fullness, with a patient preference for the 0.03% concentration.
research Bimatoprost Solution 0.03% Topical Application to the Eyelid Margin for the Treatment of Eyelash Hypotrichosis
Bimatoprost solution 0.03% is effective for treating sparse eyelashes.
research Hair-Growth Promoting Effect of Bimatoprost
Bimatoprost effectively promotes hair growth.
research The Role of Fractional Laser-Assisted Drug Delivery in Enhancing the Efficacy of Topical Bimatoprost Solution in the Treatment of Alopecia Areata: An Intra-Patient Comparative Randomized Clinical Trial
Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.
research Topical Bimatoprost (0.03%) Versus Topical Mometasone Furoate (0.1%) in Treatment of Alopecia Areata
Mometasone furoate cream was more effective than bimatoprost solution for treating hair loss from Alopecia Areata.
research Bimatoprost Promotes Hair Growth of Reconstructed Hair Follicles in Mice Through Activation of the Wnt/β-Catenin Signaling Pathway
Bimatoprost helps mouse hair grow by turning on a specific growth pathway.
research Bimatoprost for Hair Loss: Initial Studies and Application
Bimatoprost may help with hair loss.
research Bimatoprost in Androgenic Alopecia Dermatologic Treatment
Bimatoprost can help treat hair loss.
research Long-Term Safety and Efficacy of Latisse (Bimatoprost 0.03% Solution) for Treatment of Eyelash Hypotrichosis in Subjects with Chemotherapy-Induced and Idiopathic Hypotrichosis
Latisse is safe and effective for long-term eyelash growth in people with thin eyelashes from chemotherapy or unknown causes.
research Combined Microneedling With Topical Vitamin D3 or Bimatoprost Versus Microneedling Alone in the Treatment of Alopecia Areata: A Comparative Randomized Trial
Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.
research The Effect of Topical Bimatoprost 0.03% Solution on Androgenic Alopecia
Bimatoprost 0.03% solution may help treat hair loss.
research Bimatoprost for the Treatment of Female Androgenetic Alopecia: A Case Report
research A Prospective Case Series of Eyebrows Alopecia Areata Treatment With 20% TCA Application Along With Topical Bimatoprost Solution at Shadan Institute of Medical Sciences
The new treatment showed promise in managing eyebrow hair loss.
research The Effectiveness of 0.03% Bimatoprost Solution vs Minoxidil 5% in Androgenic Alopecia
research Recent Progress in Prostaglandin F2a Ethanolamide (Prostamide F2a) Research and Therapeutics
Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.
research New Onset of Alopecia Areata in a Patient with SARS-CoV-2 Infection: Possible Pathogenetic Correlations
COVID-19 infection may trigger alopecia areata in some patients.
research The Latest Innovations in Hair Transplantation
New hair transplant methods offer more natural results and better graft survival, with ongoing research to increase donor hair options.
research Prevention and Treatment of Chemotherapy-Induced Alopecia
Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.
research Treatment Options for Alopecia
The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.
research Androgens and Hair: A Biological Paradox with Clinical Consequences
Androgens can both increase body hair and cause scalp hair loss.
research Can an In Vitro Hair Drug Model Be Developed Using Dermal Papilla Cells Alone?
Dermal papilla microtissues could be useful for initial hair growth drug testing.
research Drug Repurposing in Dermatology: Molecular Biology and Omics Approach
Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.